Tuesday, 22 May 2018

Head-to-head pharmacokinetic study demonstrated greater factor IX activity with Rebinyn® versus rFIXFc in people ...

  1. Head-to-head pharmacokinetic study demonstrated greater factor IX activity with Rebinyn® versus rFIXFc in people ...  PR Newswire (press release)Full coverage
at

No comments:

Post a Comment